Diabetes, Metabolic Syndrome and Obesity

We are pleased to announce a new hot-topic Article Collection in Diabetes, Metabolic Syndrome and Obesity dedicated to the game-changing role of GLP-1 receptor agonists in type 2 diabetes and obesity. Since their clinical introduction, GLP-1 receptor agonists have revolutionized patient care, offering significant benefits in glycemic control, weight loss and management, and cardiovascular and renal diseases for eligible patients. 

Given the recognized importance of GLP-1 agonists in managing type 2 diabetes and obesity, and the accumulating new evidence showing several pleiotropic effects, Diabetes, Metabolic Syndrome and Obesity invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies. 

The Collection, edited by the Editor-In-Chief Professor Rebecca Conway and the Section Editor Professor Ernesto Maddaloni, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. 

While the call is open to receive manuscripts across the broad spectrum of GLP-1 agonists in managing type 2 diabetes and obesity, the Editors are particularly interested in manuscripts relating to the following areas:

• Obesity
• Diabetes complications, particularly cardiovascular disease, nephropathy, diabetic bone disease
• The brain (reduction in cognitive decline, addition) in diabetes
• Pediatric obesity and diabetes or type 1 diabetes

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount on the Article Publishing charge by entering the code BOUZT.

The deadline for submitting manuscripts is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health" in Diabetes, Metabolic Syndrome and Obesity.

Continuous glucose monitoring (CGM) is widely used in type 1 diabetes (T1D) to improve management and prevent dangerous fluctuations in blood glucose levels. While CGMs have long been a cornerstone of T1D care, their use is rapidly expanding beyond T1D into Type 2 diabetes (T2D) and obesity management, offering exciting possibilities for the future of diabetes care. In T2D, CGMs provide critical real-time insights into glucose fluctuations, helping patients make informed decisions about their diet, physical activity, and medication. This allows for more personalized, data-driven management, which has been shown to improve overall glycemic control and reduce the risk of complications. The true promise of CGMs, however, lies in their potential to reshape the way patients approach their health, particularly in T2D and obesity care. By offering continuous glucose feedback, CGMs help individuals better understand how their lifestyle choices - such as food intake, exercise, and stress—impact their glucose levels. This increased awareness encourages patients to make more mindful decisions and adapt their behaviors, fostering long-term, sustainable changes in their lifestyle. As individuals begin to see the direct impact of their habits on their metabolic health, they are empowered to take greater control over their condition, leading to better weight management and improved overall health outcomes. 

Looking ahead, CGMs and other emerging technologies hold the potential to revolutionize diabetes and obesity care. By providing real-time, actionable data, these technologies enable a more integrated and personalized approach to managing these conditions. This Article Collection gathers articles that explore the evolving role of CGMs and emerging diabetes management technologies in shaping the future of care for diabetes and obesity, highlighting their ability to improve patient outcomes through personalized, lifestyle-driven, and pharmacology-based interventions.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. Submitting authors will be eligible for a 10% discount on the Article Publishing charge by entering the code B91B1.

The deadline for submitting manuscripts is 31 January 2026.

Guest Advisors

Dr. Emir Muzurovic, University of Montenegro, Montenegro

[email protected]

Emir Muzurovic (MD,PhD), a physician and researcher at the Department of Internal Medicine, Endocrinology Section, Clinical Centre of Montenegro, and the Faculty of Medicine, University of Montenegro, Podgorica, Montenegro. He works on advancing the management of diabetes and metabolic health, with a focus on integrating innovative medical technologies into clinical practice. His expertise spans endocrinology, metabolic disorders, and personalized patient care.

Prof. Manfredi Rizzo, University of Palermo, Italy

[email protected]

Prof. Manfredi Rizzo, MD, PhD, a physician and researcher specializing in internal medicine, diabetes, and cardiovascular prevention. He is Associate Professor at the University of Palermo and Head of both the Unit of Diabetes and Cardiovascular Prevention and the Cardiometabolic Research Laboratory. He is an active member of various scientific societies and has authored over 250 peer-reviewed publications, with a notable H-Index of 47.

 

 

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Global Trends and Innovations in Type 1 Diabetes: Incidence, Management, and Beta-Cell Preservation" in Diabetes, Metabolic Syndrome and Obesity.

Concerns about the ongoing rise in Type 1 Diabetes (T1D) have been buoyed recently by exciting developments in approaches to easier, more effective management through automated insulin delivery and smart devices, as well as medication to delay T1D progression and use cell-based treatments—culminating in a true shift in the disease horizon. 

Given the importance of these shifts for the trajectory of the field of T1D and future management, Diabetes and Metabolic Syndrome invites submissions of original research articles, reviews, and perspectives exploring global shifts in epidemiology, pathophysiology, and transformative technology and cell-based management. 

This Collection focuses on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading improvements in patient outcomes. 

While the call is open to receive manuscripts across the broad spectrum of changes in T1D incidence and treatment, we are particularly interested in manuscripts relating to the following areas:

• Global incidence
• Technology-based management
• Treatment to prolong beta cell survival
• Cell-based treatments

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website, entering the promo code 2A26C to indicate that the paper is for consideration in this Article Collection. The deadline for submitting manuscripts is 28 February 2026.

Guest Advisor

Prof. Mark D. DeBoer, University of Virginia, USA

[email protected]

View all papers in this article collection